X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (6) 6
tamoxifen (5) 5
aromatase inhibitors - adverse effects (4) 4
breast neoplasms - drug therapy (4) 4
cancer therapies (4) 4
chemotherapy (4) 4
chemotherapy, adjuvant (4) 4
disease-free survival (4) 4
female (4) 4
humans (4) 4
index medicus (4) 4
middle aged (4) 4
oncology (4) 4
abridged index medicus (3) 3
adult (3) 3
analysis (3) 3
androstadienes - adverse effects (3) 3
androstadienes - therapeutic use (3) 3
antineoplastic agents, hormonal - adverse effects (3) 3
antineoplastic agents, hormonal - therapeutic use (3) 3
aromatase inhibitors - therapeutic use (3) 3
breast neoplasms - surgery (3) 3
care and treatment (3) 3
medicine, general & internal (3) 3
patients (3) 3
premenopause (3) 3
survival (3) 3
tamoxifen - adverse effects (3) 3
tamoxifen - therapeutic use (3) 3
women (3) 3
womens health (3) 3
610 medicine & health (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
aromatase (2) 2
article (2) 2
breast neoplasms - radiotherapy (2) 2
clinical trials (2) 2
data processing (2) 2
drug dosages (2) 2
drug therapy (2) 2
endocrine therapy (2) 2
erbb-2 protein (2) 2
estrogen (2) 2
follow-up studies (2) 2
health aspects (2) 2
invasiveness (2) 2
kaplan-meier estimate (2) 2
letrozole (2) 2
mastectomy (2) 2
post-menopause (2) 2
postmenopausal women (2) 2
quality of life (2) 2
research (2) 2
therapy (2) 2
young-women (2) 2
adjuvant (1) 1
administration & dosage (1) 1
adverse effects (1) 1
aged (1) 1
amenorrhea (1) 1
american-society (1) 1
anti-pd-1 (1) 1
antibody (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
apoptosis (1) 1
aromatase inhibitors (1) 1
aromatase inhibitors - administration & dosage (1) 1
biomarkers (1) 1
biomarkers, tumor - analysis (1) 1
biopsy (1) 1
breast neoplasms (1) 1
breast neoplasms - chemistry (1) 1
breast neoplasms - mortality (1) 1
breast neoplasms - pathology (1) 1
cancer and oncology (1) 1
cancer och onkologi (1) 1
carcinoma (1) 1
cell death (1) 1
cells (1) 1
chemistry (1) 1
clinical outcomes (1) 1
design (1) 1
dosage and administration (1) 1
drug administration schedule (1) 1
dyspnea (1) 1
efficacy (1) 1
effusion (1) 1
erbb-2 (1) 1
estradiol - blood (1) 1
exemestane (1) 1
follow-up (1) 1
gonadotropins (1) 1
health risk assessment (1) 1
hormone replacement therapy (1) 1
hormone therapy (1) 1
hospitals (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 01/2015, Volume 372, Issue 5, pp. 436 - 446
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 2, pp. 107 - 118
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2018, Volume 379, Issue 2, pp. 122 - 137
Journal Article
The Lancet Oncology, ISSN 1470-2045, 03/2019, Volume 20, Issue 3, pp. 371 - 382
HER2-positive breast cancers usually contain large amounts of T-cell infiltrate. We hypothesised that trastuzumab resistance in HER2-positive breast cancer... 
TUMOR-INFILTRATING LYMPHOCYTES | SOLID TUMORS | ONCOLOGY | ANTIBODY | PROPOSAL | TILS | ANTI-PD-1 | CARCINOMA | STANDARDIZED METHOD | PATHOLOGISTS | Antimitotic agents | Breast cancer | Antineoplastic agents | Analysis
Journal Article
by Colleoni, Marco and Luo, Weixiu and Karlsson, Per and Chirgwin, Jacquie and Aebi, Stefan and Jerusalem, Guy and Neven, Patrick and Hitre, Erika and Graas, Marie-Pascale and Simoncini, Edda and Kamby, Claus and Thompson, Alastair and Loibl, Sibylle and Gavilá, Joaquín and Kuroi, Katsumasa and Marth, Christian and Müller, Bettina and O'Reilly, Seamus and Di Lauro, Vincenzo and Gombos, Andrea and Ruhstaller, Thomas and Burstein, Harold and Ribi, Karin and Bernhard, Jürg and Viale, Giuseppe and Maibach, Rudolf and Rabaglio-Poretti, Manuela and Gelber, Richard D and Coates, Alan S and Di Leo, Angelo and Regan, Meredith M and Goldhirsch, Aron and Vandebroek, An and Berliere, Martine and Mitine, Carine and Vuylsteke, Peter and Borms, Marleen and D'Hondt, Randal and Glorieux, Philippe and Mebis, Jeroen and Verhoeven, Didier and Coibion, Michael and Forget, Frederic and Duck, Lionel and Wyendaele, Wim and Barbeaux, Annelore and Salmon, Jean-Paul and Berteloot, Patrick and Vermeij, Joanna and Richard, Vincent and Cinieri, Saverio and Gianni, Lorenzo and Clerico, Mario and Pinotti, Graziella and Bernardo, Antonio and Biganzoli, Leo and Gennari, Alessandra and Graiff, Claudio and Amadori, Dino and Passalacqua, Rodolfo and Forbes, John and Francis, Prudence and Foo, Serene and Boyle, Frances and Redfern, Andrew and van der Westhuizen, Andre and Lewis, Craig and Sharma, Ravi and Sharma, Sharad and Beale, Philip and Byard, Ian and Begbie, Stephen and Sardelic, Frank and Abdi, Ehtesham and Clark, David and Chindewere, Aaron and Della-Fiorentina, Stephen and Asghari, Ray and Islam, Mohammed and Na Teo, Lee and White, Shane and Gilbert, Linda and Gardner, Katherine and Uhlmann, Catarina and Rauch, Daniel and Mannhart, Meinrad and Buser, Katharina and Dedes, Konstantin and Mueller, Andreas and Rageth, Christoph and Von Orelli, Stephanie and Senn, Hans Joerg and Pagani, Olivia and Pedrazzini, Augusto and Rochlitz, Christoph and Bodmer, Alexandre and Anchisi, Sandro and Zaman, Khalil and von Moos, Roger and Betticher, Daniel and ... and SOLE Investigators and Institute of Clinical Sciences, Department of Oncology and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy and Institutionen för kliniska vetenskaper, Avdelningen för onkologi
The Lancet Oncology, ISSN 1470-2045, 01/2018, Volume 19, Issue 1, pp. 127 - 138
Journal Article